March 2020: Prohealth Limited, is pleased to announce the appointment of its Chief Financial Officer, Andrew Spiteri Willets to its Board of Directors, effective 1st January 2020.
Mr. Spiteri Willets, joined Prohealth in August 2015, as Finance Manager, and was subsequently appointed Chief Financial Officer in January 2018. He joins a board led by Chairman & Advisor to the board Joseph F. X. Zahra, and the company’s 3 founders: CEO Peter Apap and Executive Directors, John Jaccarini and Andrew Paris.
A University of Malta graduate, Andrew Spiteri Willets is a certified public accountant and a member of the Malta Institute of Accountants. Before joining Prohealth, he gained valuable experience holding senior positions in a variety of industries, ranging from financial services to iGaming and IT.
Welcoming Andrew to the board, Peter Apap said, that in addition to giving the company valuable financial perspective, Andrew will be in an ideal position to contribute further to the organization’s business strategy, and its operations while playing a vital role in important decisions.
Established 25 years ago, Prohealth is a distributor of pharmaceuticals, dermo-cosmetics, medical devices, and other healthcare products in Malta and other neighbouring markets. With a team of over 50 employees, the company is the trusted representative of a number of leading global brands, that include La Roche-Posay, Vichy Laboratoires, Ursapharm, Kin and Medel amongst others.